Report Id: MDNM819
Nanomedical Market Size By Indication (Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases), By Application (Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines), By Modality (Treatments, Diagnostics), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Nanomedical Market is expected to exceed more than US$ 450 Billion by 2028 at a CAGR of 10.3% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Johnson & Johnson
- Mallinckrodt plc
- Merck & Company Inc
- Nanosphere Inc
- Pfizer Inc
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
10
REPORT DESCRIPTION
The Nanomedical Market is expected to exceed more than US$ 450 Billion by 2028 at a CAGR of 10.3% in the given forecast period.
Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.
Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.
Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.
The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.
The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Nanomedical Market has been segmented as below:
Nanomedical Market, By Indication
- Ophthalmological Diseases
- Immunological Diseases
- Cardiovascular Diseases
- Oncological Diseases
- Infectious Diseases
- Orthopedic Disorders
- Neurological Diseases
- Urological Diseases
- Others
Nanomedical Market, By Application
- Implants
- Regenerative Medicine
- Diagnostic Imaging
- Drug Delivery
- Vaccines
- Others
Nanomedical Market, By Modality
- Treatments
- Diagnostics
Nanomedical Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Nanomedical Market, By Company
- Johnson & Johnson
- Mallinckrodt plc.
- Merck & Company, Inc.
- Nanosphere, Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- CombiMatrix Corporation
- General electric Company
- Sigma-Tau Pharmaceuticals, Inc.
The report covers:
- Global Nanomedical market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Nanomedical market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Nanomedical market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.
Reasons to Buy this Report:
- Gain detailed insights on the Nanomedical industry trends
- Find complete analysis on the market status
- Identify the Nanomedical market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Nanomedical Market, By Indication
5.1 Introduction
5.2 Ophthalmological Diseases
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Immunological Diseases
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Cardiovascular Diseases
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Oncological Diseases
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Infectious Diseases
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Orthopedic Disorders
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Neurological Diseases
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Urological Diseases
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Others
5.10.1 Market Overview
5.10.2 Market Size and Forecast
6. Nanomedical Market, By Application
6.1 Introduction
6.2 Implants
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Regenerative Medicine
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Diagnostic Imaging
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Drug Delivery
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Vaccines
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Others
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Nanomedical Market, By Modality
7.1 Introduction
7.2 Treatments
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Diagnostics
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Nanomedical Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Nanomedical, By Indication
8.2.2 North America Nanomedical, By Application
8.2.3 North America Nanomedical, By Modality
8.3 Europe
8.3.1 Europe Nanomedical, By Indication
8.3.2 Europe Nanomedical, By Application
8.3.3 Europe Nanomedical, By Modality
8.4 Asia-Pacific
8.4.1 Asia-Pacific Nanomedical, By Indication
8.4.2 Asia-Pacific Nanomedical, By Application
8.4.3 Asia-Pacific Nanomedical, By Modality
8.5 Rest of the World
8.5.1 Rest of the World Nanomedical, By Indication
8.5.2 Rest of the World Nanomedical, By Application
8.5.3 Rest of the World Nanomedical, By Modality
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Johnson & Johnson
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Mallinckrodt plc.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Merck & Company, Inc.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Nanosphere, Inc.
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Teva Pharmaceutical Industries Ltd.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 CombiMatrix Corporation
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 General electric Company
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Sigma-Tau Pharmaceuticals, Inc.
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Nanomedical Market has been segmented as below:
Nanomedical Market, By Indication
- Ophthalmological Diseases
- Immunological Diseases
- Cardiovascular Diseases
- Oncological Diseases
- Infectious Diseases
- Orthopedic Disorders
- Neurological Diseases
- Urological Diseases
- Others
Nanomedical Market, By Application
- Implants
- Regenerative Medicine
- Diagnostic Imaging
- Drug Delivery
- Vaccines
- Others
Nanomedical Market, By Modality
- Treatments
- Diagnostics
Nanomedical Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Nanomedical Market, By Company
- Johnson & Johnson
- Mallinckrodt plc.
- Merck & Company, Inc.
- Nanosphere, Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- CombiMatrix Corporation
- General electric Company
- Sigma-Tau Pharmaceuticals, Inc.
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Nanomedical Market?
The market is expected to grow at a CAGR of 10.3% during the study period (2023-2028)
How big is the Nanomedical Market value?
The Nanomedical Market is expected to exceed more than US$ 450 Billion by 2028
What is the segment’s covered for the Nanomedical Market?
The segment included in Nanomedical Market is Indication, Application, Modality, Company and region.
Who are the major key vendors in the Nanomedical Market?
Some key players operating in Nanomedical Market include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE